Langenbruch, Lisa
Kellinghaus, Christoph
Article History
Accepted: 12 September 2022
First Online: 4 November 2022
Declarations
:
: L. Langenbruch has received lecture honoraria from Eisai, GW Pharmaceuticals, and Biogen. C. Kellinghaus has served as a consultant to Marinus Ltd. and Neurocrine; he has received lecture fees from UCB, Eisai, Angelini Pharma, Zogenix, and GW Pharmaceuticals.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.
Free to read: This content has been made available to all.